Oral fludara of high-purity formulation with quick release of active ingredient
申请人:Schering AG
公开号:US20030176391A1
公开(公告)日:2003-09-18
This invention relates to a quick-release tablet formulation with >99.19% pure fludara (high-purity fludara) as an active ingredient in a defined composition of residual contaminants.